Luke Evans MP: written questions

490 published records · newest first.

Written questions

  • Skilled Workers: FinanceDepartment for Work and PensionsTabled 4 Jun 2026AnsweredUIN 6797More

    Question: To ask the Secretary of State for Work and Pensions, if he will make an assessment of the potential impact of differing levels of skills funding between mayoral and non-mayoral combined authorities on trends in the level of (a) educational achievement, (b

    Answer: Skills provision is funded in a number of different ways including but not limited to 16-19 funding, the Adult Skills Fund (ASF), Apprenticeships funding, and Advanced Learner Loans. There are no plans to make the proposed assessment, as the costs to do s...

    Answered 29 Jun 2026

    Original Parliament record
  • Infrastructure: FinanceMinistry of Housing, Communities and Local GovernmentTabled 4 Jun 2026AnsweredUIN 6796More

    Question: To ask the Secretary of State for Housing, Communities and Local Government, whether he will conduct an assessment of the potential impact of variable levels of infrastructure investment on the extent of regeneration and strategic upgrades achieved by may

    Answer: Given the differing roles and funding models, per capita comparisons for skills, transport and infrastructure between Mayoral Strategic Authorities and Local Authorities are not directly comparable. No direct assessment has been made on the potential effe...

    Answered 11 Jun 2026

    Original Parliament record
  • Transport: FinanceDepartment for TransportTabled 4 Jun 2026AnsweredUIN 6795More

    Question: To ask the Secretary of State for Transport, whether she will conduct an assessment of the potential impact on regional connectivity from differing levels of transport investment between mayoral and non-mayoral combined authorities.

    Answer: We are committed to evaluating the range of funding programmes and policies across local transport, and we are engaging with MHCLG on the approach to evaluation for places with integrated settlements. Additionally, we are using the Department's Connectivi...

    Answered 12 Jun 2026

    Original Parliament record
  • Health Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6794More

    Question: To ask the Secretary of State for Health and Social Care, what data is held by NHS England on the use and impact of minimum waiting time policies across Integrated Care Boards; and whether this information is collected centrally.

    Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

    Answered 22 Jun 2026

    Original Parliament record
  • Health Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6793More

    Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the compatibility of minimum waiting time policies with the NHS Constitution for England, including patients’ rights to access services within maximum wai

    Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

    Answered 22 Jun 2026

    Original Parliament record
  • Health Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6792More

    Question: To ask the Secretary of State for Health and Social Care, what guidance NHS England has issued to Integrated Care Boards on the use of minimum waiting times; and whether prior approval is required before such policies are implemented.

    Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

    Answered 22 Jun 2026

    Original Parliament record
  • Health Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6791More

    Question: To ask the Secretary of State for Health and Social Care, for which procedures, treatments or clinical pathways minimum waiting times have been applied by Integrated Care Boards; and what criteria are used to determine their application.

    Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

    Answered 22 Jun 2026

    Original Parliament record
  • Health Services: StandardsDepartment of Health and Social CareTabled 4 Jun 2026AnsweredUIN 6790More

    Question: To ask the Secretary of State for Health and Social Care, if he will list the integrated care boards that have implemented policies involving minimum waiting times for NHS treatment.

    Answer: There is no formal national policy supporting minimum waits in the National Health Service. However, the NHS Standard Contract allows local commissioners to set activity planning assumptions to plan demand, capacity, and expenditure.It is important to not...

    Answered 22 Jun 2026

    Original Parliament record
  • General Practitioners: ContractsDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6695More

    Question: To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with the General Medical Council on the potential impact of the policy on GPs’ use of advice and guidance on (a) GP indemnity and (b) patient safety.

    Answer: The Department and NHS England considered the potential impacts of expanding Advice and Guidance (A&G) as part of the policy development process, including through clinical input, established governance arrangements, and equalities considerations. A&a...

    Answered 18 Jun 2026

    Original Parliament record
  • General Practitioners: ContractsDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6694More

    Question: To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with the Care Quality Commission on the potential impact of the policy on GPs’ use of advice and guidance on (a) GP indemnity and (b) patient safety.

    Answer: The Department and NHS England considered the potential impacts of expanding Advice and Guidance (A&G) as part of the policy development process, including through clinical input, established governance arrangements, and equalities considerations. A&a...

    Answered 18 Jun 2026

    Original Parliament record
  • General Practitioners: ContractsDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6693More

    Question: To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the impact on patient safety of his policy on GPs’ use of advice and guidance.

    Answer: The Department and NHS England considered the potential impacts of expanding Advice and Guidance (A&G) as part of the policy development process, including through clinical input, established governance arrangements, and equalities considerations. A&a...

    Answered 18 Jun 2026

    Original Parliament record
  • Drugs: VATDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6626More

    Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential risk that pharmaceutical companies could withdraw compassionate access programmes due to VAT-related financial pressures.

    Answer: The Government recognises the important role that compassionate and expanded access programmes can play in enabling patients, particularly those with serious or rare conditions, to access innovative medicines outside routine commissioning arrangements.VAT...

    Answered 10 Jun 2026

    Original Parliament record
  • NHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6017More

    Question: To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of compassionate or expanded access schemes affected by VAT-related costs, including any schemes that have been withdrawn.

    Answer: The Department is working closely with HM Treasury and HM Revenue and Customs to explore options in relation to the VAT treatment of medicines supplied free of charge to the National Health Service, including those provided through compassionate use and e...

    Answered 22 Jun 2026

    Original Parliament record
  • NHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6016More

    Question: To ask the Secretary of State for Health and Social Care, whether he has held recent discussions with colleagues in the Treasury on the pause in applying VAT to compassionate medicines programmes.

    Answer: The Department is working closely with HM Treasury and HM Revenue and Customs to explore options in relation to the VAT treatment of medicines supplied free of charge to the National Health Service, including those provided through compassionate use and e...

    Answered 22 Jun 2026

    Original Parliament record
  • NHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6015More

    Question: To ask the Secretary of State for Health and Social Care, what recent discussions he has had with the Chancellor of the Exchequer on exempting compassionate medicines programmes from VAT.

    Answer: The Department is working closely with HM Treasury and HM Revenue and Customs to explore options in relation to the VAT treatment of medicines supplied free of charge to the National Health Service, including those provided through compassionate use and e...

    Answered 22 Jun 2026

    Original Parliament record
  • Cancer: ChildrenDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6014More

    Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact on children with relapsed or rare cancers of reduced availability of compassionate access to innovative therapies.

    Answer: The Government recognises the importance of enabling timely access to innovative medicines, particularly for patients with rare and life‑threatening conditions, including children with relapsed or rare cancers.The availability of medicines through company...

    Answered 22 Jun 2026

    Original Parliament record
  • NHS: DrugsDepartment of Health and Social CareTabled 2 Jun 2026AnsweredUIN 6013More

    Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to provide patients with continuity of access to compassionate medicines following the withdrawal by some pharmaceutical companies of early access scheme medicines.

    Answer: The Government recognises the importance of enabling timely access to innovative medicines, particularly for patients with rare and life‑threatening conditions, including children with relapsed or rare cancers.The availability of medicines through company...

    Answered 22 Jun 2026

    Original Parliament record
  • Drugs: VATTreasuryTabled 1 Jun 2026AnsweredUIN 5411More

    Question: To ask the Chancellor of the Exchequer, what engagement she has undertaken with families, clinicians and charities to discuss the impact of VAT on compassionate access programme medicines.

    Answer: Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair if a business has reclaimed VAT on costs. Whether VAT applies to medicines or tre...

    Answered 4 Jun 2026

    Original Parliament record
  • Drugs: VATTreasuryTabled 1 Jun 2026AnsweredUIN 5410More

    Question: To ask the Chancellor of the Exchequer, what discussions she has had with the Secretary of State for Health and Social Care on the potential impact of VAT policy on compassionate medicines access.

    Answer: Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair if a business has reclaimed VAT on costs. Whether VAT applies to medicines or tre...

    Answered 4 Jun 2026

    Original Parliament record
  • Drugs: VATTreasuryTabled 1 Jun 2026AnsweredUIN 5409More

    Question: To ask the Chancellor of the Exchequer, what recent discussions her Department has held on the alteration of VAT to palliative care medicines supplied free of charge for children.

    Answer: Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair if a business has reclaimed VAT on costs. Whether VAT applies to medicines or tre...

    Answered 4 Jun 2026

    Original Parliament record
  • Drugs: VATTreasuryTabled 1 Jun 2026AnsweredUIN 5408More

    Question: To ask the Chancellor of the Exchequer, what categories of compassionate or expanded access scheme medicines are currently within the scope of VAT.

    Answer: Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair if a business has reclaimed VAT on costs. Whether VAT applies to medicines or tre...

    Answered 4 Jun 2026

    Original Parliament record
  • Drugs: VATTreasuryTabled 1 Jun 2026AnsweredUIN 5407More

    Question: To ask the Chancellor of the Exchequer, how long the current pause in applying VAT to compassionate medicines programmes will remain in place.

    Answer: Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair if a business has reclaimed VAT on costs. Whether VAT applies to medicines or tre...

    Answered 4 Jun 2026

    Original Parliament record
  • Drugs: VATTreasuryTabled 1 Jun 2026AnsweredUIN 5406More

    Question: To ask the Chancellor of the Exchequer, what estimate her Department has made of how much money it would expect to gain through the application of VAT to compassionate medicine programmes.

    Answer: Under UK VAT law, some transactions where no money changes hands are treated as if a supply has been made – these are called deemed supplies. This is to keep the system fair if a business has reclaimed VAT on costs. Whether VAT applies to medicines or tre...

    Answered 4 Jun 2026

    Original Parliament record
  • Pets: Export Health CertificatesDepartment for Environment, Food and Rural AffairsTabled 1 Jun 2026AnsweredUIN 5405More

    Question: To ask the Secretary of State for Environment, Food and Rural Affairs, pursuant to the Answer of 27 May 2026 to Question 286 on Pets: EU Countries, if she will have discussions with Improve International to consider opportunities to increase the number of

    Answer: There are currently no plans to hold any discussions with Improve International on the number of Official Veterinarians who can issue Animal Health Certificates. Defra is aware of the numerous challenges facing the veterinary sector, including recruitment...

    Answered 10 Jun 2026

    Original Parliament record
  • Special Educational Needs: StaffDepartment for EducationTabled 1 Jun 2026AnsweredUIN 5404More

    Question: To ask the Secretary of State for Education, if she will consider developing a national workforce plan to support councils and other bodies to determine resources for future SEND provision needs.

    Answer: The department is working closely with the Department of Health and Social Care (DHSC) and NHS England on special educational needs and disabilities (SEND) reforms, including delivery of the Experts at Hand offer and strengthening joint workforce planning...

    Answered 8 Jul 2026

    Original Parliament record

Published records only — not a full account of an MP’s work. How we work →